For more information about the EXTEND study or to find out if you are eligible, please contact the site closest to you.
EXTEND is no longer recruiting participants.
Preserving beta cell function with tocilizumab in new onset type 1 diabetes.
EXTEND is no longer recruiting participants
For more information about the EXTEND study or to find out if you are eligible, please contact the site closest to you.
EXTEND is no longer recruiting participants.